Prostate News Archive
01-Nov-2011
Exelixis Falls on FDA Prostate Cancer Trial Design Setback
SOUTH SAN FRANCISCO, Calif. (TheStreet) -- Exelixis faces the possibility of a lengthy delay in the approval process for its experimental prostate cancer drug cabozantinib because U.S. regulators are refusing to sign off on the design of a pivotal clinical trial. The setback introduces new risk into the development of the promising prostate cancer drug, which caused investors to flee Exelixis ... Prostate Cancer Expert Dr. David Samadi to Perform Life-Saving Robotic Prostatectomy Surgery in Netherlands
NEW YORK, NY-- - prostate cancer expert, Dr. David Samadi, continues his dedication to improving medical care worldwide and increasing accessibility of medical technology by traveling to the Netherlands ... Prostate Cancer Patients Considering Suicide May Find Help in New Concept
Oct. 31, 2011 - Men with prostate cancer are twice as likely to commit suicide, but a method where they put intrusive thoughts into words may reduce this risk, reveals research at the Sahlgrenska Academy at the University of Gothenburg, Sweden. New findings could lower risk of suicide in men with prostate cancer
Men with prostate cancer are twice as likely to commit suicide, but a method where they put intrusive thoughts into words may reduce this risk, reveals research at the Sahlgrenska Academy at the University of Gothenburg, Sweden. Prostate Cancer Roundtable Expresses Concern over Federal Recommendations Impeding Access to the PSA, a Key Cancer ...
Contact: Scott Williams, +1-202-543-6461 ext. 101
Back to Prostate News Archive
